Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus

키워드

참고문헌 (35)

1. Younossi ZM, "Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008", Clin Gastroenterol Hepatol, 9, pp.524~530 (2011)
2. Younossi ZM, "The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe", Hepatology, 64, pp.1577~1586 (2016)
3. Lonardo A, "Nonalcoholic fatty liver disease : a precursor of the metabolic syndrome", Dig Liver Dis, 47, pp.181~190 (2015)
4. Yang KC, "Association of non-alcoholic fatty liver disease with metabolic syndrome independently of central obesity and insulin resistance", Sci Rep, 6, pp.27034~ (2016)
5. Kannel WB, "Diabetes and cardiovascular risk factors : the Framingham study", Circulation, 59, pp.8~13 (1979)
6. Jemal A, "Trends in the leading causes of death in the United States, 1970-2002", JAMA, 294, pp.1255~1259 (2005)
7. Anstee QM, "Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis", Nat Rev Gastroenterol Hepatol, 10, pp.330~344 (2013)
8. Park SK, "Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men : 5-year prospective cohort study", Hepatology, 57, pp.1378~1383 (2013)
9. Kim SS, "Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in nonobese subjects", Dig Liver Dis, 50, pp.370~377 (2018)
10. Mantovani A, "Nonalcoholic fatty liver disease and risk of incident type 2 diabetes : a meta-analysis", Diabetes Care, 41, pp.372~382 (2018)
11. Chang Y, "Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population", Am J Gastroenterol, 108, pp.1861~1868 (2013)
12. Choi JH, "Increased risk of type 2 diabetes in subjects with both elevated liver enzymes and ultrasonographically diagnosed nonalcoholic fatty liver disease : a 4-year longitudinal study", Arch Med Res, 44, pp.115~120 (2013)
13. Sung KC, "Resolution of fatty liver and risk of incident diabetes", J Clin Endocrinol Metab, 98, pp.3637~3643 (2013)
14. Yamazaki H, "Independent association between improvement of nonalcoholic fatty liver disease and reduced incidence of type 2 diabetes", Diabetes Care, 38, pp.1673~1679 (2015)
15. Angulo P, "GI epidemiology : nonalcoholic fatty liver disease", Aliment Pharmacol Ther, 25, pp.883~889 (2007)
16. Tarantino G, "Non-alcoholic fatty liver disease : further expression of the metabolic syndrome", J Gastroenterol Hepatol, 22, pp.293~303 (2007)
17. Mancini M, "Sonographic hepaticrenal ratio as indicator of hepatic steatosis : comparison with(1)H magnetic resonance spectroscopy", Metabolism, 58, pp.1724~1730 (2009)
18. Strauss S, "Interobserver and intraobserver variability in the sonographic assessment of fatty liver", AJR Am J Roentgenol, 189, pp.W320~W323 (2007)
19. American Diabetes Association, "2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018", Diabetes Care, 41(Suppl 1), pp.S13~S27 (2018)
20. Bedogni G, "The fatty liver index : a simple and accurate predictor of hepatic steatosis in the general population", BMC Gastroenterol, 6, pp.33~ (2006)
21. Yang BL, "External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross-sectional study in Taiwan", PLoS One, 10, pp.e0120443~ (2015)
22. Huang X, "Validation of the fatty liver index for nonalcoholic fatty liver disease in middle-aged and elderly Chinese", Medicine (Baltimore), 94, pp.e1682~ (2015)
23. Rowland ML, "Self-reported weight and height", Am J Clin Nutr, 52, pp.1125~1133 (1990)
24. Jeong Ah Kim, "Cut-off Values of Visceral Fat Area and Waist Circumference: Diagnostic Criteria for Abdominal Obesity in a Korean Population", Journal of Korean Medical Science, 21(6), pp.1048~1053 (2006), 대한의학회
25. Liu Q, "The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease(NAFLD)", Lipids Health Dis, 9, pp.42~ (2010)
26. Neuschwander-Tetri BA, "Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis : the central role of nontriglyceride fatty acid metabolites", Hepatology, 52, pp.774~788 (2010)
27. Li YX, "Insulin resistance caused by lipotoxicity is related to oxidative stress and endoplasmic reticulum stress in LPL gene knockout heterozygous mice", Atherosclerosis, 239, pp.276~282 (2015)
28. Adams LA, "NAFLD as a risk factor for the development of diabetes and the metabolic syndrome : an eleven-year follow-up study", Am J Gastroenterol, 104, pp.861~867 (2009)
29. Shibata M, "Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men", Diabetes Care, 30, pp.2940~2944 (2007)
30. Ballestri S, "Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis", J Gastroenterol Hepatol, 31, pp.936~944 (2016)
31. Danaei G, "National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980 : systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2∙7 million participants", Lancet, 378, pp.31~40 (2011)
32. Prati D, "Updated definitions of healthy ranges for serum alanine aminotransferase levels", Ann Intern Med, 137, pp.1~10 (2002)
33. Vozarova B, "High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes", Diabetes, 51, pp.1889~1895 (2002)
34. Sattar N, "Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study", Diabetes, 53, pp.2855~2860 (2004)
35. Kim D, "Nonobese fatty liver disease", Clin Gastroenterol Hepatol, 15, pp.474~485 (2017)

관련 논문AI추천